Complement inhibition ameliorates blast-induced acute lung injury in rats: Potential role of complement in intracellular HMGB1-mediated inflammation
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Complement inhibition ameliorates blast-induced acute lung injury in rats: Potential role of complement in intracellular HMGB1-mediated inflammation
Authors
Keywords
Inflammation, Cytokines, Complement activation, Transcription factors, Complement inhibitors, Pulmonary imaging, Traumatic injury, Complement system
Journal
PLoS One
Volume 13, Issue 8, Pages e0202594
Publisher
Public Library of Science (PLoS)
Online
2018-08-23
DOI
10.1371/journal.pone.0202594
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antiapoptotic Effect of Recombinant HMGB1 A-box Protein via Regulation of microRNA-21 in Myocardial Ischemia-Reperfusion Injury Model in Rats
- (2016) Qiang Han et al. DNA AND CELL BIOLOGY
- A novel “complement-metabolism-inflammasome axis” as a key regulator of immune cell effector function
- (2016) Giuseppina Arbore et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Complement component C3a plays a critical role in endothelial activation and leukocyte recruitment into the brain
- (2016) Fengjiao Wu et al. Journal of Neuroinflammation
- Therapeutic targeting of acute lung injury and acute respiratory distress syndrome
- (2016) Theodore J. Standiford et al. Translational Research
- Involvement of high mobility group box 1 in the activation of C5a-primed neutrophils induced by ANCA
- (2015) Chen Wang et al. CLINICAL IMMUNOLOGY
- Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation
- (2015) Xiaorong Zhu et al. JOURNAL OF CLINICAL INVESTIGATION
- TLR4-HMGB1-, MyD88- and TRIF-dependent signaling in mouse intestinal ischemia/reperfusion injury
- (2015) Jie Wang WORLD JOURNAL OF GASTROENTEROLOGY
- HMGB1 Develops Enhanced Proinflammatory Activity by Binding to Cytokines
- (2014) Y. Sha et al. JOURNAL OF IMMUNOLOGY
- HMGB1 in health and disease
- (2014) Rui Kang et al. MOLECULAR ASPECTS OF MEDICINE
- Traumatic Brain Injury: Lungs in a RAGE
- (2014) M. R. Nicolls et al. Science Translational Medicine
- Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injury
- (2014) Maria Entezari et al. Redox Biology
- C3a modulates IL-1 secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation
- (2013) E. Asgari et al. BLOOD
- The complexity of NF-κB signaling in inflammation and cancer
- (2013) Bastian Hoesel et al. Molecular Cancer
- Protective effects of decay-accelerating factor on blast-induced neurotrauma in rats
- (2013) Yansong Li et al. Acta Neuropathologica Communications
- C5L2: a controversial receptor of complement anaphylatoxin, C5a
- (2012) Rui Li et al. FASEB JOURNAL
- HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4
- (2012) Milena Schiraldi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Decay-accelerating factor limits hemorrhage-instigated tissue injury and improves resuscitation clinical parameters
- (2012) Jurandir J. Dalle Lucca et al. JOURNAL OF SURGICAL RESEARCH
- Blast-induced moderate neurotrauma (BINT) elicits early complement activation and tumor necrosis factor alpha (TNFα) release in a rat brain
- (2012) Jurandir J. Dalle Lucca et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Combat wounds in Iraq and Afghanistan from 2005 to 2009
- (2012) Philip J. Belmont et al. Journal of Trauma and Acute Care Surgery
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
- (2012) Shigeki Chiba et al. NATURE IMMUNOLOGY
- Effects of C1 Inhibitor on Tissue Damage in a Porcine Model of Controlled Hemorrhage
- (2012) Jurandir J. Dalle Lucca et al. SHOCK
- Complement Inhibition Alleviates Paraquat-Induced Acute Lung Injury
- (2011) Shihui Sun et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
- (2011) Ulf Andersson et al. Annual Review of Immunology
- High-Mobility Group Box 1 Is Essential for Mitochondrial Quality Control
- (2011) Daolin Tang et al. Cell Metabolism
- Decay-Accelerating Factor Mitigates Controlled Hemorrhage-Instigated Intestinal and Lung Tissue Damage and Hyperkalemia in Swine
- (2011) Jurandir J. Dalle Lucca et al. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE
- Incidence of Primary Blast Injury in US Military Overseas Contingency Operations
- (2010) Amber E. Ritenour et al. ANNALS OF SURGERY
- Complement C3a, CpG Oligos, and DNA/C3a Complex Stimulate IFN- Production in a Receptor for Advanced Glycation End Product-Dependent Manner
- (2010) B. H. Ruan et al. JOURNAL OF IMMUNOLOGY
- Inhibitor of NF- B Kinases and Are Both Essential for High Mobility Group Box 1-Mediated Chemotaxis
- (2010) M. Penzo et al. JOURNAL OF IMMUNOLOGY
- Decay accelerating factor (CD55) protects neuronal cells from chemical hypoxia-induced injury
- (2010) Ying Wang et al. Journal of Neuroinflammation
- A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
- (2010) H. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Complement C3 Plays an Essential Role in the Control of Opportunistic Fungal Infections
- (2009) S. V. Tsoni et al. INFECTION AND IMMUNITY
- Decay-Accelerating Factor Attenuates C-Reactive Protein-Potentiated Tissue Injury After Mesenteric Ischemia/Reperfusion
- (2009) Xinyue Lu et al. JOURNAL OF SURGICAL RESEARCH
- ATTENUATION OF PULMONARY INFLAMMATION AFTER EXPOSURE TO BLAST OVERPRESSURE BY N-ACETYLCYSTEINE AMIDE
- (2009) Mikulas Chavko et al. SHOCK
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More